Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation

被引:20
作者
Steffen, Jan
Maneva, Galina
Poplawska, Lidia
Varon, Raymonda
Mioduszewska, Olga
Sperling, Karl
机构
[1] M Sklodowska Curie Mem Canc Ctr, Dept Immunol, PL-02781 Warsaw, Poland
[2] Inst Oncol, Warsaw, Poland
[3] Humboldt Univ, Charite, Inst Human Genet, Berlin, Germany
[4] Maria Sklodowska Curie Mem Canc Ctr, Dept Lymphoproliferat Dis, Warsaw, Poland
[5] Inst Oncol, Warsaw, Poland
[6] M Sklodowska Curie Mem Canc Ctr, Dept Pathol, Warsaw, Poland
关键词
NBS1; 657del5; mutations; non-Hodgkin lymphoma;
D O I
10.1002/ijc.22280
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The NBS1 gene mutation, 657del5, frequent in the Slavic populations of Central Europe, is found in most patients with Nijmegen breakage syndrome (NBS), a recessive autosomal disorder with a very high incidence of non-Hodgkin lymphoma (NHL). We have previously described 2 heterozygous 657del5 mutation carriers among 42 adult NHL probands from Central Poland. Here we report 6 additional carriers of the 657del5 mutation and 2 carriers of the pathogenic NBS1 R215W mutation, among 186 other NHL patients also from Central Poland. The 657del5 carrier frequency in the pooled group of these 228 patients was significantly higher than in population controls (OR 5.85, 95% CI: 2.29-15.00, p = 0.0001). Interestingly, 4 of these carriers were found among 37 patients with gastrointestinal lymphoma (OR 19.52, 95% CI: 5.82-65.42, p = 0.0002). These findings imply that heterozygous NBS1 germline mutations may contribute significantly to the overall incidence of NHL, especially of the gastrointestinal tract, in Central Europe. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:2970 / 2973
页数:4
相关论文
共 34 条
[1]  
BORISCH B, 2001, WHO CLASSIFICATION T, P257
[2]   Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma [J].
Cerosaletti, KM ;
Morrison, VA ;
Sabath, DE ;
Willerford, DM ;
Concannon, P .
GENES CHROMOSOMES & CANCER, 2002, 35 (03) :282-286
[3]   Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies [J].
Chrzanowska, KH ;
Piekutowska-Abramczuk, D ;
Popowska, E ;
Gladkowska-Dura, M ;
Maldyk, J ;
Syczewska, M ;
Krajewska-Walasek, M ;
Goryluk-Kozakiewicz, B ;
Bubala, H ;
Gadomski, A ;
Gaworczyk, A ;
Kazanowska, B ;
Koltan, A ;
Kuzmicz, M ;
Luszawska-Kutrzeba, T ;
Maciejka-Kapuscinska, L ;
Stolarska, M ;
Stefanska, K ;
Sznurkowska, K ;
Wakulinska, A ;
Wieczorek, M ;
Szczepanski, T ;
Kowalczyk, J .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (05) :1269-1274
[4]   An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability [J].
Demuth, I ;
Frappart, PO ;
Hildebrand, G ;
Melchers, A ;
Lobitz, S ;
Stöckl, L ;
Varon, R ;
Herceg, Z ;
Sperling, K ;
Wang, ZQ ;
Digweed, M .
HUMAN MOLECULAR GENETICS, 2004, 13 (20) :2385-2397
[5]   Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks [J].
Digweed, M ;
Sperling, K .
DNA REPAIR, 2004, 3 (8-9) :1207-1217
[6]  
Dumon-Jones V, 2003, CANCER RES, V63, P7263
[7]  
Hama S, 2000, ANTICANCER RES, V20, P1897
[8]  
HAMILTONDUTOIT SJ, 1993, BLOOD, V82, P619
[9]   World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3835-3849
[10]  
Hiel JA, 2000, ARCH DIS CHILD, V82, P400